Clinical Trials Insight: 700023098
Latest Information Update: 09 Jun 2009
At a glance
- Drugs Bezisterim (Primary)
- Indications Multiple sclerosis; Rheumatoid arthritis; Type 2 diabetes mellitus; Ulcerative colitis
- Focus Adverse reactions
- Sponsors Harbor Therapeutics
- 11 May 2007 New trial record.